ReviewMedical oncology (Northwood, London, England)2025

Harnessing GSK-3β inhibition for lung cancer therapy: emerging opportunities and challenges.

Emad H M Hassanein et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.